Certara, Inc. (CERT) vs Kailera Therapeutics, Inc. (KLRA)
A side-by-side comparison of Certara, Inc. and Kailera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERT
Certara, Inc.
$9.39HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
KLRA
Kailera Therapeutics, Inc.
$10.76HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — CERT vs KLRA
growth of $100 · dividends reinvested · last 1yCERT +63.5% (+63.5%/yr)KLRA -58.3% (-58.3%/yr)CERT compounded faster over this window
CERT KLRA
CERT vs KLRA: by the numbers
- •CERT is the larger company ($1.46B vs $1.39B market cap).
- •Both run net losses; KLRA's is the smaller (0.00% vs -16.75% net margin).
Metrics side by side
Valuation
| Metric | CERT | KLRA |
|---|---|---|
| Forward P/E | 27.57 | N/A |
| P/S ratio | 3.58 | N/A |
| P/B ratio | 1.51 | 1.25 |
| EV / EBITDA | 26.56 | N/A |
| FCF yield | 4.22% | N/A |
Profitability
| Metric | CERT | KLRA |
|---|---|---|
| Gross margin | 58.33% | 0.00% |
| Operating margin | 1.86% | 0.00% |
| Net margin | -16.75% | 0.00% |
| ROE | -7.08% | N/A |
| ROIC | 0.59% | -24.52% |
Growth (annualized)
| Metric | CERT | KLRA |
|---|---|---|
| Revenue CAGR (5Y) | 9.31% | N/A |
| FCF CAGR (5Y) | 8.78% | N/A |
| Total return CAGR (5Y) | -21.31% | N/A |
Go deeper
Dig into the metrics
Certara ROEKailera Therapeutics ROECertara operating marginKailera Therapeutics operating marginCertara revenue growthKailera Therapeutics revenue growthCertara free cash flowKailera Therapeutics free cash flow
Certara & Kailera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.